Persistence with first line anticholinergic medication in treatment-naive overactive bladder patients

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10290560" target="_blank" >RIV/00216208:11110/14:10290560 - isvavai.cz</a>

Alternative codes found

RIV/00843989:_____/14:E0103889

Result on the web

<a href="http://dx.doi.org/10.3109/21681805.2013.814707" target="_blank" >http://dx.doi.org/10.3109/21681805.2013.814707</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3109/21681805.2013.814707" target="_blank" >10.3109/21681805.2013.814707</a>

Result language

angličtina

Original language name

Persistence with first line anticholinergic medication in treatment-naive overactive bladder patients

Original language description

Objective. The aim of this study was to evaluate the persistence of first line anticholinergic medication use by patients with overactive bladder (OAB). Data from a hospital outpatient database were matched with information obtained by a telephone surveyof patients to determine which patients discontinued use of anticholinergic medication and to identify the reasons underlying discontinuation. Material and methods. The study group included 377 OAB patients (52 men, 325 women) with a mean age of 60.29 +/- 13.84 years. In total, 189 patients (50.1%) were treated with trospium (median dose 27.86 +/- 12.73 mg), 41 patients (10.9%) with propiverine (28.17 +/- 4.97 mg), nine patients (2.4%) with extended-release tolterodine (4.0 +/- 0 mg), 48 patients (12.7%) with solifenacin (5.94 +/- 1.97 mg) and 90 patients (23.9%) with fesoterodine (6.09 +/- 2.01 mg). Results. The median time for persistence with the first line anticholinergic treatment was 6.53 +/- 3.84 months. Persistence was signific

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FE - Other fields of internal medicine

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2014

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Scandinavian Journal of Urology

ISSN

2168-1805

e-ISSN

—

Volume of the periodical

48

Issue of the periodical within the volume

1

Country of publishing house

GB - UNITED KINGDOM

Number of pages

5

Pages from-to

79-83

UT code for WoS article

000332420100011

EID of the result in the Scopus database

—